The FDA has upgraded the recall of over 54,000 bottles of levothyroxine sodium tablets to Class II after finding potency issues that could cause temporary or reversible health effects. Levothyroxine, a synthetic thyroid hormone used for hypothyroidism, is the third most prescribed U.S. drug. Manufactured by India’s Intas Pharmaceuticals—already under FDA scrutiny—the inconsistent dosing raises major quality control concerns for millions relying on stable hormone therapy.
North America
© Prepping Communities. This content is for informational purposes only and not professional advice. Use at your own risk.
Terms | Privacy | Guidelines